17 March 2022 Ankylosing Spondylitis Biologics Pharmacy Guild of Australia Mavrilimumab opens up GCA promise
10 March 2022 Ankylosing Spondylitis Gout Juvenile Arthritis Pharmacy Guild of Australia Ross River Virus Promising findings on steroid-sparing options for PMR and GCA
9 December 2021 Biologics Pharmacy Guild of Australia New treatments offer fresh hope for GCA patients
9 November 2021 Ankylosing Spondylitis Biologics Gout Pharmacy Guild of Australia What’s on the way for GCA?
8 November 2021 COVID-19 Pharmacy Guild of Australia Reactive Arthritis Technology Day 2 conference highlights
5 August 2021 Pharmacy Guild of Australia Psoriatic Athritis Spondyloarthritis Tocilizumab shortage: clinical management advice
4 November 2020 Analgesics Conditions Pharmacy Guild of Australia COVID or giant cell arteritis: how to spot the difference
4 November 2020 Conditions Pharmacy Guild of Australia Ross River Virus Overcoming challenges in GCA and PMR management
18 June 2020 Analgesics Conditions Pharmacy Guild of Australia Three-year GiACTA trial results unveiled
18 June 2019 Analgesics Conditions Pharmacy Guild of Australia What part 2 of the GiACTA trial means for Australia
